Tag: Indian Pharma
-
Exclusive Interview: US Tax Policy Impact on Indian Pharma
Overview: US Tax Policy and Indian Pharma The Trump administration’s second term has been marked by a push toward protectionist tax measures, tariffs, and tighter control on foreign-based operations. In this context, India’s booming pharmaceutical industry—an ecosystem where the United States represents a major, sometimes dominant market—faces questions about how new fiscal rules might reshape…
-
Impact of U.S. Tariffs on Indian Pharma Industry: Interview Insights
The U.S. Tariff Landscape and Its Implications The recent implementation of tariffs by the United States on imported pharmaceuticals has raised questions about its impact on India’s robust pharmaceutical sector. Rajiv Nannapaneni, CEO of Natco Pharma, emphasized that despite these tariffs, the Indian pharmaceutical industry is unlikely to face significant adverse effects. With 92% of…